The business itself and the acquisition multiple is fine but geez, the consideration price for the shares is another slap in the face to shareholders! I wonder what Mathew Walker thinks of his top 5 holding in the company atm...
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game